Evolent Health (EVH) Long-Term Debt Repayments (2023 - 2025)
Evolent Health's quarterly Long-Term Debt Repayments came in at $113.7 million in Q4 2025, down 31.8% quarter-over-quarter from $166.8 million in Q3 2025.
Evolent Health has reported Long-Term Debt Repayments for 2 years, with the latest figure at $113.7 million in Q4 2025.
- For the quarter ending Q4 2025, Long-Term Debt Repayments changed N/A year-over-year to $113.7 million; the trailing twelve-month figure through Mar 2026 stood at $280.5 million (up 348.77% YoY), and the FY2025 full-year result was $343.0 million, changed N/A from the prior year.
- Long-Term Debt Repayments for Q4 2025 stood at $113.7 million, down from $166.8 million in the prior quarter.
- The five-year high for Long-Term Debt Repayments was $416.7 million in Q4 2023, with the low at $10.0 million in Q3 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | - |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 12.35 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 15.00 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | - |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | - |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 23.55 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | - |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | - |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | - |
| 10 | Evolent Health | 467.76 Mn | 301.79 Mn | 83.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 113.73 Mn |
| Dec 31, 2025 | 113.73 Mn |
| Sep 30, 2025 | 166.76 Mn |
| Sep 30, 2025 | 166.76 Mn |
| Mar 31, 2025 | 62.50 Mn |
| Mar 31, 2025 | 62.50 Mn |
| Dec 31, 2023 | 416.70 Mn |
| Dec 31, 2023 | 416.70 Mn |
| Sep 30, 2023 | 10.00 Mn |
| Sep 30, 2023 | 10.00 Mn |
| Mar 31, 2023 | 37.50 Mn |
| Mar 31, 2023 | 37.50 Mn |